Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 36 % of short-term debt in 2025; threshold 65 %.
-
Figures corrected NBB
Corrected annual account filed for 2023.
Financials
Financial year 2025
PHARMACIE DE MANGOMBROUX from Verviers, company number BE0784996155, closed financial year 2025 with a result of € 9,527 after tax. For that financial year PHARMACIE DE MANGOMBROUX recorded a gross margin of € 279,612 and equity of € 29,518. Compared with financial year 2024, the result moved from € 10,857 to € 9,527. The company is profitable. The buffer shrank hard: equity is 58 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 9, 2026.
€ 29,518
▼ 58% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 9,527
▼ 12% vs 2024
Profit after tax over the fiscal year.
€ 127,659
▲ 47% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 50,000 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
3.7
▲ 0.4 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 189,601
▲ 2% vs 2024
€ 51,200 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 133,809
▼ 22% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 106,085
▲ 25% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 30,693
▼ 28% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 222,190 | € 306,067 | € 308,894 | € 279,612 | ▼ 9% |
| Profit after taxes | € 24,602 | € 14,532 | € 10,857 | € 9,527 | ▼ 12% |
| Equity | € 44,602 | € 59,134 | € 69,991 | € 29,518 | ▼ 58% |
| Total debts | € 745,025 | € 684,225 | € 630,868 | € 626,177 | ▼ 1% |
| Cash | € 85,205 | € 40,017 | € 86,800 | € 127,659 | ▲ 47% |
| Land & buildings | € 1,980 | € 5,562 | € 6,878 | € 6,410 | ▼ 7% |
| Retained profit | € 24,602 | € 39,134 | € 49,991 | € 9,518 | ▼ 81% |
| Dividend | € 0 | € 0 | € 0 | € 50,000 | |
| Balance sheet total | € 789,627 | € 743,358 | € 700,859 | € 655,695 | ▼ 6% |
| Employees (FTE) | 2 | 3.3 | 3.3 | 3.7 | ▲ 0.4 |
Key figures of PHARMACIE DE MANGOMBROUX, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PHARMACIE DE MANGOMBROUX?
What happened at PHARMACIE DE MANGOMBROUX in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 9,527 (▼ 12% vs 2024). Source: NBB ↗
- New establishment in Verviers. KBO
- VALERIE MATHONET became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 24,602 profit in 2022 to € 9,527 profit in 2025.
Paid € 29,262 in corporate taxes since 2022.
Best year ever: 2022, with € 24,602 profit.
On average € 75,600 of value added per employee in 2025.
A new publication or filing at PHARMACIE DE MANGOMBROUX? We notify you, reason included.
Follow PHARMACIE DE MANGOMBROUXDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind PHARMACIE DE MANGOMBROUX is VALERIE MATHONET. VALERIE MATHONET is also behind Union Pharmaceutique des Arrondissements Judiciaire de Verviers et Eupen.
Directors
According to the 2025 annual accounts
VALERIE MATHONET
Director
Also active at: Union Pharmaceutique des Arrondissements Judiciaire de Verviers et Eupen
since 2022
Establishments
Establishment units
Physical locations of this company
Avenue Reine Astrid 256
4802 Verviers
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Microsoft 365
Hosting
OVH, FR
Website info
Features
Security
Details
- Company number
- 0784.996.155
- VAT number
- BE 0784.996.155
- Registered office
- Avenue Reine Astrid 256, 4802 Verviers
- Names & denominations
- PHARMACIE DE MANGOMBROUX
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 20 April 2022
- Peppol
- Active · Active since 8 Sept 2025
- Contact
- pharmaciemangombroux.be
- Activities · NACE
Detailhandel in farmaceutische producten
Verhuur en lease van medisch en paramedisch materieel
Detailhandel in cosmetica en toiletartikelen
Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen
Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels